Nano-shields: Exploring the role of antioxidant mimicking nanoparticles as regenerative therapy in spinal cord injury
Source abstract
Abstract
Spinal cord injury presents a significant clinical challenge. There are limited treatment options, and the results of regeneration are often disappointing. Secondary injury processes, including oxidative stress and chronic inflammation, worsen nerve damage and slow recovery. New nanomaterials, particularly antioxidant-mimicking nanoparticles known as nanozymes, offer a promising way to improve the injury microenvironment and aid nerve regeneration. These nanozymes mimic natural enzyme activity by scavenging reactive oxygen species and reducing inflammation. Materials like cerium oxide, gold, and platinum-based nanoparticles show strong catalytic and antioxidant abilities. Their effectiveness is influenced by factors like pH, redox state, and levels of hydrogen peroxide or glutathione. Their stability, adaptability, and ability to be produced on a large scale make them promising options in regenerative medicine and drug development. In this special issue, we offer an overview of the development, functions, and healing potential of nanozyme-based systems for spinal cord injury. We highlight their potential as next-generation materials for nerve repair.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (96)
Show source-provided references
1. Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms10.3389/fneur.2019.00282 ↗
2. Epidemiology of worldwide spinal cord injury: a literature review
3. Different ways to die: cell death pathways and their association with spinal cord injury10.14245/ns.2244976.488 ↗
4. Challenges in drug development for neurological disorders
5. Drug repurposing for spinal cord injury: progress towards therapeutic intervention for primary factors and secondary complications10.1007/s40290-023-00499-3 ↗
6. Asymmetric catalytic hydrogenation. Design of new Ru catalysts and chiral ligands: from laboratory to industrial applications10.1021/ar020152u ↗
7. Bioorthogonal chemistry: fishing for selectivity in a sea of functionality10.1002/anie.200900942 ↗
8. Mechanism of oxidation reactions catalysed by cytochrome p450 enzymes10.1021/cr020443g ↗
9. Wu · 2019 · 48(4) · 1004
10. Zhang · 2021 · 2(7) · 534
11. Wei · 2013 · 42(14) · 6060
12. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles10.1038/nnano.2007.260 ↗
13. Recent advances in nanozyme research10.1002/adma.201805368 ↗
14. Nanozyme: new horizons for responsive biomedical applications10.1039/C8CS00718G ↗
15. Jiang · 2019 · 48(14) · 3683
16. Nanozymes: classification, catalytic mechanisms, activity regulation, and applications10.1021/acs.chemrev.8b00672 ↗
17. Nanomaterials exhibiting enzyme-like properties (nanozymes): current advances and future perspectives10.3389/fchem.2019.00046 ↗
18. Bukhtiyarov · 2001 · 70(2) · 147
19. From hope to healing: exploring the therapeutic potential of exosomes in spinal cord injury10.1016/j.vesic.2024.100044 ↗
20. The role of nanomaterials in modulating the structure and function of biomimetic catalysts10.3389/fchem.2020.00764 ↗
21. Tonga · 2015 · 7(7) · 597
22. Malik · 2023
23. Mesoporous silica-encapsulated gold nanoparticles as artificial enzymes for self-activated cascade catalysis10.1016/j.biomaterials.2013.01.007 ↗
24. Vernekar · 2014 · 5(1) · 5301
25. Tran · 2018 · 98(2) · 881
26. Colton · 2013 · 8 · 145
27. Oyinbo · 2011 · 71(2) · 281
28. Garcia · 2016 · 2016
29. Birben · 2012 · 5 · 9
30. Zorov · 2014 · 94(3) · 909
31. Nita · 2016 · 2016
32. Oxidative stress: harms and benefits for human health10.1155/2017/8416763 ↗
33. Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases10.3389/fphys.2020.00694 ↗
34. Vascular oxidative stress: impact and therapeutic approaches10.3389/fphys.2018.01668 ↗
35. Bioinspired copper single-atom nanozyme as a superoxide dismutase-like antioxidant for sepsis treatment
36. Liu · 2021 · 13 · 1
37. From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration10.3389/fphar.2023.1269581 ↗
38. Sims · 2018 · 30(8) · 085703
39. A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties10.1016/j.freeradbiomed.2004.07.002 ↗
40. Gao · 2023 · 14(1) · 160
41. Liu · 2023 · 33(19) · 2213856
42. Ma · 2022 · 14(5) · 6358
43. Zhang · 2021 · 41 · 101317
44. Thao · 2023 · 14(5) · 1017
45. Li · 2015 · 48 · 37
46. Rotruck · 1973 · 179(4073) · 588
47. Huang · 2017 · 53(21) · 3082
48. Li · 2022 · 623 · 787
49. Singh · 2017 · 129(45) · 14455
50. Zhang · 2023 · 13(8) · 2492
51. Nanozymes in biomedicine: unraveling trends, research foci, and future trajectories via bibliometric insights (from 2007 to 2024)10.1016/j.ijbiomac.2025.142798 ↗
52. The application of peroxidase mimetic nanozymes in cancer diagnosis and therapy10.3389/fphar.2024.1339580 ↗
53. Exploring the relationship between antioxidant enzymes, oxidative stress markers, and clinical profile in relapsing-remitting multiple sclerosis
54. Recent progress in the rational design and applications of nanozymes10.1016/j.bioana.2025.02.001 ↗
55. Phenserine mitigates neuroinflammation, apoptosis, and behavioural deficits to enhance motor function and recovery in a mouse model of spinal cord injury
56. Treatment with ascorbic acid and α-tocopherol modulates oxidative-stress markers in the spinal cord of rats with neuropathic pain10.1590/1414-431x20177097 ↗
57. Biochemistry of antioxidants: mechanisms and pharmaceutical applications10.3390/biomedicines10123051 ↗
58. Bhattacharyya · 2014 · 94(2) · 329
59. Fan · 2022 · 10(1) · 35
60. Lin · 2022 · 91
61. Chinnock, P. and I.J.C.D.o.S.R. Roberts, Gangliosides for Acute Spinal Cord Injury. 2005(2).10.1002/14651858.CD004444.pub2 ↗
62. M1/M2 macrophages and their overlaps - myth or reality?10.1042/CS20220531 ↗
63. Tan · 2018 · 9 · 402374
64. Antioxidant nanozymes: current status and future perspectives in spinal cord injury treatments10.7150/thno.114836 ↗
65. Advancements in Antioxidant-based Therapeutics for Spinal Cord Injury: A Critical Review of Strategies and Combination Approaches
66. Recent advances in nanomaterials for the treatment of spinal cord injury10.1016/j.mtbio.2022.100524 ↗
67. Designing hydrogels for controlled drug delivery10.1038/natrevmats.2016.71 ↗
68. Nanopharmaceutics: part I-clinical trials legislation and good manufacturing practices (GMP) of nanotherapeutics in the EU10.3390/pharmaceutics12020146 ↗
69. Nanotherapeutic and stem cell therapeutic strategies in neurodegenerative diseases: a promising therapeutic approach10.2147/IJN.S395010 ↗
70. Nanoparticle formulations of antioxidants for the management of oxidative stress in stroke: a review10.3390/biomedicines11113010 ↗
71. Antioxidant functionalized nanoparticles: a combat against oxidative stress10.3390/nano10071334 ↗
72. Therapy of spinal cord injury by zinc pyrogallol modified nanozyme via anti-inflammatory strategies10.1016/j.cej.2023.144595 ↗
73. A review of biodegradable natural polymer-based nanoparticles for drug delivery applications10.3390/nano10101970 ↗
74. A manganese oxide nanozyme prevents the oxidative damage of biomolecules without affecting the endogenous antioxidant system
75. Manganese oxide nanozymes ameliorate mechanical allodynia in a rat model of partial sciatic nerve-transection induced neuropathic pain10.2147/IJN.S225594 ↗
76. Multienzymatic antioxidant activity of manganese-based nanoparticles for protection against oxidative cell damage
77. Designing multifunctionalized selenium nanoparticles to reverse oxidative stress-induced spinal cord injury by attenuating ROS overproduction and mitochondria dysfunction10.1039/C8TB02520G ↗
78. Selenium attenuates ROS-mediated apoptotic cell death of injured spinal cord through prevention of mitochondria dysfunction; in vitro and in vivo study10.1159/000113764 ↗
79. Single-atom cobalt nanozymes promote spinal cord injury recovery by anti-oxidation and neuroprotection10.1007/s12274-023-5588-z ↗
80. Therapy of spinal cord injury by zinc modified gold nanoclusters via immune-suppressing strategies10.1186/s12951-021-01035-8 ↗
81. Badgujar · 2016 · 31(9) · 1147
82. Crisp · 2015 · 125(7) · 2772
83. Andrabi · 2020 · 317 · 300
84. Polymeric nanostructures containing proteins and peptides for pharmaceutical applications10.3390/polym14040777 ↗
85. Multilayer polyion complex nanoformulations of superoxide dismutase 1 for acute spinal cord injury
86. Xiong · 2023 · 10(7) · 2205997
87. ROS scavenging Mn(3)O(4) nanozymes for in vivo anti-inflammation10.1039/C7SC05476A ↗
88. The importance of selenium to human health10.1016/S0140-6736(00)02490-9 ↗
89. Selenium in the therapy of neurological diseases. Where is it going?10.2174/1570159X14666151223100011 ↗
90. Physiological benefits of novel selenium delivery via nanoparticles10.3390/ijms24076068 ↗
91. Effects of cerium oxide nanoparticles on PC12 neuronal-like cells: proliferation, differentiation, and dopamine secretion10.1007/s11095-013-1071-y ↗
92. Effect of cerium oxide nanoparticles on oxidative stress biomarkers in rats’ kidney, lung, and serum10.29252/ibj.24.4.251 ↗
93. Cerium oxide nanoparticles in neuroprotection and considerations for efficacy and safety10.1002/wnan.1444 ↗
94. Functional recovery of contused spinal cord in rat with the injection of optimal-dosed cerium oxide nanoparticles
95. Overcoming the blood-brain barrier: the role of nanomaterials in treating neurological diseases10.1002/adma.201801362 ↗
96. Application of artificial intelligence in the exploration and optimisation of biomedical nanomaterials